This slide set collectively provides a basic introduction to the care of HIV for clinicians. It was designed for use with corrections providers but could be applicable to any beginning HIV care provider. (Brochure)

The History of HIV
Jeffery A. Beal, M.D.

The speaker will briefly review the natural history of HIV and the different target sites for drug therapy before discussing the current DHHS guidelines. A brief review of the history and pharmacology of the different antiretrovirals will be presented. This session will also review information and guidelines regarding HIV post-exposure prophylaxis both occupational (Post-Exposure - PEP) and non-occupational Sex or contaminated injection equipment - nPEP), as well as the developing body of knowledge and investigation of pre-exposure prophylaxis (PrEP).
(Slides)

Antiretroviral Therapy: Drugs, Mechanism of Action, Adverse Effects
Joanne J. Orrick, Pharm.D., B.C.P.S.

The speaker will review the currently available antiretroviral agents including mechanism of action and adverse effect profile. The speaker will also briefly review drugs on the horizon.
(Slides)

Starting Treatment – Clinical Presentations
Ernesto J. Lamadrid, M.D.

This session will cover the latest DHHS guidelines for starting HAART. Different inmate populations will be discussed along with their risk and benefit of starting treatment. Clinical presentation will be used to illustrate the timing and selection of starting treatment criteria.
(Slides)

Antiretroviral Drug Interactions
Joanne J. Orrick, Pharm.D., B.C.P.S.

The speaker will review the basic principles of drug interactions including types of drug interactions. The speaker will review the most common or significant potential drug interactions involving the antiretrorival agents.
(Slides)

Adherence vs. Resistance
Ernesto J. Lamadrid, M.D.

This session will cover the importance of adherence in the HIV+ patient. Different types of medication distribution will be discussed along with pros and cons. The mechanism of creating resistance will be illustrated along with strategies for prevention of resistance.
(Slides)

Into the Lab
Stanley M. Dratler, M.D.

This session will cover the lab work required by DOC for its HIV clinic as well as basic lab values. This presentation will also provide a basic overview of resistance testing for the practitioner who is just starting out in the treatment of HIV-infected patients or those wanting a refresher on the fundamentals of resistance testing. The following topics will be reviewed in this presentation: guidelines for the use of resistance testing, overview of available resistance tests, and resources for resistance testing interpretation.
(Slides)

HIV and the other Players
Jeffery A. Beal, M.D.

This session will discuss the co-morbid conditions that either affect the treatment of HIV or are affected by the disease. As the long-term survival in HIV infection has improved, chronic illnesses such as hepatitis and TB have emerged as significant agents of cormorbidity and early mortality. The speaker will present an overview of the epidemiology of viral hepatitis in HIV and recommendations for screening and prevention. Treatment of hepatitis B and C continues to evolve, especially in HIV. An overview of current management will be discussed.
(Slides)

Manifestations in HIV
Carol M. Stewart, D.D.S.

Oral lesions may be the first clinical features of HIV infection and can lead to its diagnosis. Their presence is an indication of immunodeficiency and predicts the progression of HIV disease. This training will present basic information on dental issues and oral manifestations, giving practical information for treatment and prevention.
(Slides)

Panel of Experts Q & A
All Faculty

All lecturers will be on dais and will answer written anonymous questions from the audience as well as present actual case presentations.